FDC Peer Comparison

NSE: FDC | BSE: 531599

₹356.25

₹4.85 (1.38%)

As on 16-Oct-2026IST

Market cap

₹5,807 Cr

Revenue (TTM)

₹2,190 Cr

P/E Ratio

19.9

P/B Ratio

2.2

Div. Yield

1.4 %

Edit

	FDC	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Market cap (₹ Cr)	5,807	18,336	17,484	17,475	15,832
Revenue (₹ Cr)	2,190	1,682	2,287	2,570	3,230
Net Profit (₹ Cr)	292.56	273.51	678.07	735.15	666.92
Net Margin (%)	12.56	16.19	28.10	26.88	20.60
RoE (%)	12.56	11.15	19.73	19.16	18.75
Price to Earnings	19.85	61.67	26.28	23.77	24.59
Price-To-Book	2.22	6.83	4.76	3.97	3.93

Income Statement (₹ Cr)

	FDC	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Operating Revenue	2,190.22	1,682.47	2,287.33	2,569.77	3,229.67
Total Income	2,329.19	1,689.83	2,413.29	2,735.39	3,237.12
Total Expenditure	1,854.76	1,203.91	1,490.75	1,628.14	2,090.06
EBITDA	335.46	478.55	796.58	941.63	1,139.61
Depreciation	59.47	126.01	78.10	57.58	281.06
EBIT	275.99	352.55	718.48	884.05	858.55
Interest	4.65	52.11	0.88	7.69	190.64
Other Income	138.97	7.37	125.96	165.62	7.45
Exceptional Items	-20.79	12.16	0.00	-49.16	-17.24
Profit before Tax	389.52	319.96	843.56	992.82	658.12
Provision for Tax	96.96	46.45	165.49	257.67	-8.80
Profit after Tax	292.56	273.51	678.07	735.15	666.92

	FDC	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Shareholder's Funds	2,485.11	2,591.20	3,586.42	4,202.90	3,902.67
Minority Interest	0.00	0.00	-12.71	0.00	-21.81
Non-Current Liabilities	69.78	266.35	28.74	91.50	1,392.75
Current Liabilities	364.08	848.06	385.94	627.48	2,077.10
Total Liabilities	3,938.74	3,705.61	4,037.51	4,921.88	7,246.72

	FDC	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Non-Current Assets	1,628.07	2,525.44	1,291.22	770.28	5,617.77
Current Assets	1,132.52	1,109.77	2,585.66	3,803.22	1,539.85
Total Assets	3,938.74	3,705.61	4,037.51	4,921.88	7,246.72
Total Debt*	0.00	657.97	0.57	2.50	2,309.68
Net Current Assets	768.45	261.71	2,199.72	3,175.74	-537.25
Contingent Liabilities	204.54	160.01	17.53	370.49	51.57

	FDC	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Cash From Operating Activities	200.45	342.18	523.24	967.57	537.99
Cash Flow from Investing Activities	-109.93	-325.92	-582.30	-561.67	-369.46
Cash from Financing Activities	-93.33	13.62	-46.46	-798.31	-313.53
Net Cash Inflow / Outflow	-2.80	29.88	-105.52	-392.41	-145.00

	FDC	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
ROCE (%)	15.93	11.43	24.97	23.39	14.47
ROE (%)	12.56	11.15	19.73	19.16	18.75
ROA (%)	10.39	7.80	18.69	14.95	9.26
EBIT Margin (%)	12.60	20.95	31.41	34.40	26.58
Net Margin (%)	12.56	16.19	28.10	26.88	20.60
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	FDC	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Revenue Growth (%)	3.40	27.91	15.01	10.69	9.59
EBIT Growth (%)	8.85	58.32	18.45	24.14	16.84
Net Profit Growth (%)	8.72	149.56	19.61	-9.09	62.68
EPS Growth (%)	14.73	-3.57	17.73	14.40	67.41
Book Value Growth (%)	8.94	9.67	26.75	-0.34	36.71

	FDC	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Price / Earnings	18.81	65.42	26.28	22.65	23.97
Price / Book Value	2.22	6.83	4.76	3.97	3.93
Dividend Yield (%)	1.40	0.06	0.35	1.96	0.00
EV/EBITDA	15.75	39.60	20.69	15.26	15.86
Market Cap (₹ Cr)	5,229.56	6,819.66	11,439.22	21,592.90	17,980.08

	FDC	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Debt to Equity	0.00	0.07	0.00	0.00	0.24
Short term debt to equity ratio	--	0.16	0.00	0.00	0.12
Current Ratio	3.11	1.31	6.70	6.06	0.74
Quick Ratio	2.13	0.88	5.59	5.31	0.53
Interest Coverage	84.79	7.14	959.59	130.11	4.45

	FDC	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Debtors to sales (%)	6.93	30.84	36.10	7.07	21.07
Asset Turnover	0.78	0.48	0.63	0.52	0.45
Receivable days	21.28	113.81	121.68	26.06	63.88
Inventory Days	59.64	84.76	63.83	65.95	43.27
Payable days	105.74	101.94	108.28	81.01	151.85
Cash Conversion Cycle	-24.83	96.62	77.23	11.00	-44.70

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.